Introduction 

California encephalitis, a group of viral infections affecting the central nervous system, poses a serious health threat that demands our attention. While often overshadowed by more well-known diseases, the impact of California encephalitis on adults should not be underestimated. Characterized by neurological symptoms and transmitted primarily through mosquito bites, this infectious disease warrants a holistic understanding of its symptoms, risk factors, and preventive measures, facilitating early intervention and treatment.

As we delve into the intricacies of California encephalitis, it becomes apparent that awareness is key in mitigating its impact on public health. From subtle initial symptoms to severe neurological complications, the journey through this viral infection is complex. This article aims to provide comprehension encompassing California encephalitis, shedding light on its symptoms in adults, the factors that heighten vulnerability, and the strategies for both prevention and management

Background on California encephalitis 

Definition and types 

Encephalitis is the medical term for inflammation or swelling of the brain.¹ Typically, anyone can be affected, however, it is more common in the very young or old, potentially due to underdeveloped or weakened immune systems.¹ This condition can be life-threatening and, therefore, requires immediate medical intervention to mitigate serious implications. 

The California encephalitis virus belongs to a group of viruses of the family Bunyaviridae and genus Bunyavirus, alongside the La Crosse virus, Jamestown Canyon virus, and Tahyna virus.² Of these viruses, the La Crosse and California encephalitis, and Jamestown Canyon viruses are common causes of California encephalitis in the United States, with the Tahyna virus causing disease in Russia.

However, the prior virus La Crosse, is the predominant cause of the disease within the California encephalitis group. This specific virus has a serotype, a distinct feature within the virus, that is most commonly associated with human disease.²

Transmission and geographical prevalence

The La Crosse virus is endemic to the midwestern United States and Canada.² Moreover, the first case of California encephalitis was first reported in the encephalitic post-mortem examination of a child in La Crosse, Wisconsin.² Transmission occurs through mosquito bites, which become infected through feeding on mammals such as chipmunks and squirrels, however, the virus cannot be spread through human transmission such as coughing, sneezing, touching or other forms of contact.³

Common symptoms

The ratio of no symptomatic (asymptomatic) to symptomatic presentation is 1000 : 1, indicating that most people whoare infected with the La Crosse virus do not have any symptoms.² However, the 0.1% of people that do have manifestations of the infection, typically present within 5-15 days of being bitten by the mosquito.

Symptoms can be divided into an initial and a later, more severe stage. Initial symptoms can include typically symptoms of a viral infection such as:⁴

• Headache 
• Nausea
• Vomiting
• Fatigue (tiredness)
• Lethargy (reduced energy, activity or alertness)

These symptoms usually last 2 to 3 days before developing into more severe symptoms, unless the individual seeks medical intervention at this stage and is treated.⁴ 

Encephalitic symptoms of the La Crosse virus include:⁴

• High fever
• Headache
• Neck stiffness
• Stupor
• Disorientation
• Coma
• Tremors
• Seizures (that may be recurrent)
• Muscle weakness
• Numbness
• Paralysis
• Raised pressure in the brain (raised intracranial pressure), or
• A shift in brain tissue (Cerebral herniation)

This virus can cause severe disease and although most individuals will recover, death does occur rarely, with less than 1% incidence.⁴

Risk factors 

The groups most at risk of encephalitis are:⁵

• older adults
• children under the age of 1 (the La Crosse virus commonly affects children <16 years old) 
• individuals with weak immune systems

It is important to understand that anyone in an area where this virus circulates can become infected.⁶ The risk is also higher for people who live, work, or recreate in woodland habitats, because of greater exposure to potentially infected mosquitoes.⁶

Diagnosis 

Healthcare professionals will diagnose a La Crosse viral infection based on:⁴ 

• Signs and symptoms that the individual presents with 
• A history of living in or travelling to an area where the LAC virus is known to circulate
• History of possible exposure to the mosquitoes that can carry LAC virus
• Laboratory testing of blood or spinal fluid

A differential diagnosis can also be provided by a healthcare provider by ordering tests to look for the La Crosse viral infection or other infections that cause similar symptoms.⁴

Treatment and management 

Currently, no antiviral therapy exists for the California encephalitis group of viruses, and no vaccine is available.² Although antibiotics may be thought to be a viable treatment for an infection, they are not suitable for viral infections.

Most individuals return to normal function without intervention, or in the case of initial symptoms, rest, fluids, and over-the-counter pain medications may relieve some symptoms.⁴ However, in the case of more severe symptoms of California encephalitis, patients may require medical treatment to aid breathing, hydration or to reduce brain inflammation.⁴

Summary

The exploration of California encephalitis underscores the complex interplay between vector-borne viruses and the human nervous system. As we dissected the intricate clinical manifestations in adults, it became evident that vigilance and early recognition are paramount in mitigating the potential severity of this viral threat. The multifaceted nature of California encephalitis, stemming from the diverse viruses within the California serogroup, necessitates a nuanced understanding of effective prevention and management

Our scientific inquiry delved into the diagnostic challenges, treatment modalities, and the ongoing efforts in research to bridge the gaps in our understanding of these viruses. The gravity of this viral infection extends beyond the clinical realm, urging a comprehensive public health approach. Emphasizing the importance of community awareness, and implementing targeted control measures such as the understanding of risk factors and geographical occurrences, can foster pivotal protection against California encephalitis.

As we navigate the evolving landscape of infectious diseases, California encephalitis serves as a poignant reminder of the intricate dynamics between pathogens, vectors, and human hosts. Through continued scientific inquiry, proactive public health strategies, and a collective commitment to knowledge dissemination, we can work towards minimizing the impact of California encephalitis on adults, ultimately striving for a healthier and more resilient society.